175 related articles for article (PubMed ID: 23940564)
1. Combination of intratumoral invariant natural killer T cells and interferon-gamma is associated with prognosis of hepatocellular carcinoma after curative resection.
Xiao YS; Gao Q; Xu XN; Li YW; Ju MJ; Cai MY; Dai CX; Hu J; Qiu SJ; Zhou J; Fan J
PLoS One; 2013; 8(8):e70345. PubMed ID: 23940564
[TBL] [Abstract][Full Text] [Related]
2. Serum interferon gamma level predicts recurrence in hepatocellular carcinoma patients after curative treatments.
Lee IC; Huang YH; Chau GY; Huo TI; Su CW; Wu JC; Lin HC
Int J Cancer; 2013 Dec; 133(12):2895-902. PubMed ID: 23749461
[TBL] [Abstract][Full Text] [Related]
3. Impaired lipid biosynthesis hinders anti-tumor efficacy of intratumoral iNKT cells.
Fu S; He K; Tian C; Sun H; Zhu C; Bai S; Liu J; Wu Q; Xie D; Yue T; Shen Z; Dai Q; Yu X; Zhu S; Liu G; Zhou R; Duan S; Tian Z; Xu T; Wang H; Bai L
Nat Commun; 2020 Jan; 11(1):438. PubMed ID: 31974378
[TBL] [Abstract][Full Text] [Related]
4. Intratumoral neutrophils: a poor prognostic factor for hepatocellular carcinoma following resection.
Li YW; Qiu SJ; Fan J; Zhou J; Gao Q; Xiao YS; Xu YF
J Hepatol; 2011 Mar; 54(3):497-505. PubMed ID: 21112656
[TBL] [Abstract][Full Text] [Related]
5. Cytokeratin 10 and cytokeratin 19: predictive markers for poor prognosis in hepatocellular carcinoma patients after curative resection.
Yang XR; Xu Y; Shi GM; Fan J; Zhou J; Ji Y; Sun HC; Qiu SJ; Yu B; Gao Q; He YZ; Qin WZ; Chen RX; Yang GH; Wu B; Lu Q; Wu ZQ; Tang ZY
Clin Cancer Res; 2008 Jun; 14(12):3850-9. PubMed ID: 18559605
[TBL] [Abstract][Full Text] [Related]
6. Adoptive Transfer of Autologous Invariant Natural Killer T Cells as Immunotherapy for Advanced Hepatocellular Carcinoma: A Phase I Clinical Trial.
Gao Y; Guo J; Bao X; Xiong F; Ma Y; Tan B; Yu L; Zhao Y; Lu J
Oncologist; 2021 Nov; 26(11):e1919-e1930. PubMed ID: 34255901
[TBL] [Abstract][Full Text] [Related]
7. Expression of connective tissue growth factor and interleukin-11 in intratumoral tissue is associated with poor survival after curative resection of hepatocellular carcinoma.
Xiang ZL; Zeng ZC; Fan J; Tang ZY; Zeng HY
Mol Biol Rep; 2012 May; 39(5):6001-6. PubMed ID: 22205539
[TBL] [Abstract][Full Text] [Related]
8. Combination of NKT14m and Low Dose IL-12 Promotes Invariant Natural Killer T Cell IFN-γ Production and Tumor Control.
Guan P; Schaub R; Nichols KE; Das R
Int J Mol Sci; 2020 Jul; 21(14):. PubMed ID: 32708464
[TBL] [Abstract][Full Text] [Related]
9. Preoperative serum liver enzyme markers for predicting early recurrence after curative resection of hepatocellular carcinoma.
Wang ZX; Jiang CP; Cao Y; Zhang G; Chen WB; Ding YT
Hepatobiliary Pancreat Dis Int; 2015 Apr; 14(2):178-85. PubMed ID: 25865691
[TBL] [Abstract][Full Text] [Related]
10. Peritumoral Cbl is a strong independent prognostic marker after curative resection of hepatocellular carcinoma.
Zhang JB; Zhang B; Guo L; Lin ZH; Li XQ; Guo K; Sun HC; Ye QH
Oncotarget; 2015 Nov; 6(37):40223-34. PubMed ID: 26474280
[TBL] [Abstract][Full Text] [Related]
11. High expression of macrophage colony-stimulating factor in peritumoral liver tissue is associated with poor survival after curative resection of hepatocellular carcinoma.
Zhu XD; Zhang JB; Zhuang PY; Zhu HG; Zhang W; Xiong YQ; Wu WZ; Wang L; Tang ZY; Sun HC
J Clin Oncol; 2008 Jun; 26(16):2707-16. PubMed ID: 18509183
[TBL] [Abstract][Full Text] [Related]
12. Natural killer cell activity is a risk factor for the recurrence risk after curative treatment of hepatocellular carcinoma.
Lee HA; Goh HG; Lee YS; Jung YK; Kim JH; Yim HJ; Lee MG; An H; Jeen YT; Yeon JE; Byun KS; Seo YS
BMC Gastroenterol; 2021 Jun; 21(1):258. PubMed ID: 34118869
[TBL] [Abstract][Full Text] [Related]
13. Long-Chain Acylcarnitines Induce Senescence of Invariant Natural Killer T Cells in Hepatocellular Carcinoma.
Cheng X; Tan X; Wang W; Zhang Z; Zhu R; Wu M; Li M; Chen Y; Liang Z; Zhu P; Wu X; Weng X
Cancer Res; 2023 Feb; 83(4):582-594. PubMed ID: 36512635
[TBL] [Abstract][Full Text] [Related]
14. Intratumoral balance of regulatory and cytotoxic T cells is associated with prognosis of hepatocellular carcinoma after resection.
Gao Q; Qiu SJ; Fan J; Zhou J; Wang XY; Xiao YS; Xu Y; Li YW; Tang ZY
J Clin Oncol; 2007 Jun; 25(18):2586-93. PubMed ID: 17577038
[TBL] [Abstract][Full Text] [Related]
15. Human invariant natural killer T cells acquire transient innate responsiveness via histone H4 acetylation induced by weak TCR stimulation.
Wang X; Bishop KA; Hegde S; Rodenkirch LA; Pike JW; Gumperz JE
J Exp Med; 2012 May; 209(5):987-1000. PubMed ID: 22508835
[TBL] [Abstract][Full Text] [Related]
16. High STAT4 expression is a better prognostic indicator in patients with hepatocellular carcinoma after hepatectomy.
Wubetu GY; Utsunomiya T; Ishikawa D; Yamada S; Ikemoto T; Morine Y; Iwahashi S; Saito Y; Arakawa Y; Imura S; Kanamoto M; Zhu C; Bando Y; Shimada M
Ann Surg Oncol; 2014 Dec; 21 Suppl 4():S721-8. PubMed ID: 24965572
[TBL] [Abstract][Full Text] [Related]
17. Role of cytokine gene polymorphisms on prognosis in hepatocellular carcinoma after radical surgery resection.
Pan D; Zeng X; Yu H; Yang Y; Bei C; Bai H; Qiu X
Gene; 2014 Jul; 544(1):32-40. PubMed ID: 24768182
[TBL] [Abstract][Full Text] [Related]
18. Transcriptional regulator Bhlhe40 works as a cofactor of T-bet in the regulation of IFN-γ production in iNKT cells.
Kanda M; Yamanaka H; Kojo S; Usui Y; Honda H; Sotomaru Y; Harada M; Taniguchi M; Suzuki N; Atsumi T; Wada H; Baghdadi M; Seino K
Proc Natl Acad Sci U S A; 2016 Jun; 113(24):E3394-402. PubMed ID: 27226296
[TBL] [Abstract][Full Text] [Related]
19. Serosal invasion strongly associated with recurrence after curative hepatic resection of hepatocellular carcinoma: a retrospective study of 214 consecutive cases.
Sonohara F; Nomoto S; Inokawa Y; Kanda M; Yamada S; Fujii T; Sugimoto H; Kodera Y
Medicine (Baltimore); 2015 Mar; 94(9):e602. PubMed ID: 25738484
[TBL] [Abstract][Full Text] [Related]
20. Lymphocyte-to-monocyte ratio predicts survival of patients with hepatocellular carcinoma after curative resection.
Lin ZX; Ruan DY; Li Y; Wu DH; Ma XK; Chen J; Chen ZH; Li X; Wang TT; Lin Q; Wen JY; Wu XY
World J Gastroenterol; 2015 Oct; 21(38):10898-906. PubMed ID: 26478681
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
